Proton therapy for early stage prostate cancer: is there a case?
Proton-beam therapy (PBT) for prostate cancer has been in used for several decades, with its technique evolving significantly over this period. A growing number of centers now routinely utilize pencil-beam scanning as an advanced technique of PBT. Interest and controversy concerning its use have recently come under scrutiny. While the past decade has produced an assemblage of evidence suggesting that PBT is safe and effective for early stage prostate cancer, it is still unknown whether the theoretical dosimetric advantages of PBT translate into meaningful clinical improvements over routine intensity-modulated radiation therapy, which is commonly used for these patients. Outcomes from early trials using whole courses of PBT have shown mixed results when compared with routine intensity-modulated radiation therapy. Therefore, randomized trials comparing these two techniques should be undertaken, as this would help in defining the role of PBT for this patient group. This article aims to describe the basics of PBT, review the reasons for the growing interest in PBT, review the evidence for PBT, review the controversy surrounding PBT, and inquire about PBT's future in the treatment of prostate cancer, with attention to its physical properties, comparative clinical and cost-effectiveness, and advances in its delivery.
Department of Radiation Oncology, National University Cancer Institute, Singapore.
Tabitha Y
TY
Chan
Department of Radiation Oncology, National University Cancer Institute, Singapore.
Poh Wee
PW
Tan
Department of Radiation Oncology, National University Cancer Institute, Singapore.
Johann I
JI
Tang
clinical outcomes; controversies; future direction; prostate cancer; proton beam; radiation
Cancer J. 2010 Sep-Oct;16(5):405-9
20890135
Prostate Cancer. 2012;2012:654861
22848840
Int J Radiat Oncol Biol Phys. 2010 Nov 15;78(4):1081-5
20207497
Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):1005-9
20932675
Int J Radiat Oncol Biol Phys. 2001 Mar 1;49(3):685-98
11172950
Int J Radiat Oncol Biol Phys. 2007 Aug 1;68(5):1424-30
17544601
Cancer J. 2009 Jul-Aug;15(4):312-8
19672148
Int J Radiat Oncol Biol Phys. 2012 Dec 1;84(5):1172-8
22537541
Int J Radiat Oncol Biol Phys. 2011 Jul 15;80(4):1056-63
21147514
Phys Med Biol. 2012 Nov 7;57(21):7117-32
23051714
J Clin Oncol. 2011 May 20;29(15):2020-6
21464418
Int J Radiat Oncol Biol Phys. 2008 Mar 1;70(3):744-51
17904306
Rev Assoc Med Bras (1992). 2015 Jan-Feb;61(1):8-16
25909199
J Clin Oncol. 2007 Aug 20;25(24):3603-8
17704408
Int J Radiat Oncol Biol Phys. 2008 Mar 1;70(3):654-6
18262083
Int J Radiat Oncol Biol Phys. 2008 Nov 15;72(4):980-8
18495377
J Clin Oncol. 2010 Mar 1;28(7):1106-11
20124169
Int J Radiat Oncol Biol Phys. 2010 Jul 1;77(3):773-83
19836155
Lancet Oncol. 2012 Jan;13(1):43-54
22169269
J Clin Oncol. 2006 May 1;24(13):1990-6
16648499
Int J Radiat Oncol Biol Phys. 2011 Jul 1;80(3):928-37
20947266
Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):213-21
21093164
Int J Radiat Oncol Biol Phys. 2012 Oct 1;84(2):390-5
22342302
Eur Urol. 2011 Nov;60(5):908-16
21684064
Phys Med Biol. 2008 Mar 7;53(5):1413-24
18296770
Qual Life Res. 2011 Dec;20(10):1609-15
21452085
Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):408-18
22133626
Int J Radiat Oncol Biol Phys. 2007 Feb 1;67(2):620-9
17236979
Int J Radiat Oncol Biol Phys. 2011 Aug 1;80(5):1589-600
21167651
Int J Radiat Oncol Biol Phys. 2010 Aug 1;77(5):1477-85
19879701
Int J Radiat Oncol Biol Phys. 2000 Apr 1;47(1):103-13
10758311
Int J Radiat Oncol Biol Phys. 2008 Apr 1;70(5):1478-86
18060703
Psychooncology. 2002 Jul-Aug;11(4):307-26
12203744
Int J Radiat Oncol Biol Phys. 2008 Jan 1;70(1):67-74
17765406
J Urol. 2002 Jun;167(6):2448-52
11992055
Am J Clin Oncol. 2014 Dec;37(6):525-7
24577165
Eur Urol. 2012 Jan;61(1):112-27
22001105
Cancer. 2006 Sep 1;107(5):991-8
16878323
Acta Oncol. 2013 Apr;52(3):580-8
22909391
Jpn J Clin Oncol. 2005 Dec;35(12):745-52
16314345
Int J Urol. 2010 Feb;17(2):125-38
20039976
Int J Radiat Oncol Biol Phys. 1997 Aug 1;39(1):85-9
9300743
Cancer. 2008 Jan 1;112(1):61-8
18040996
Radiat Oncol. 2009 Sep 09;4:34
19740429
Int J Radiat Oncol Biol Phys. 2008 Mar 15;70(4):1130-7
17881142
Med Dosim. 2009 Fall;34(3):191-201
19647628
Int J Radiat Oncol Biol Phys. 2012 Mar 1;82(3):1222-6
21570206
Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):e325-34
21498008
Phys Med Biol. 2010 May 21;55(10):2879-91
20427856
Med Phys. 2010 Jan;37(1):311-21
20175494
Z Med Phys. 2004;14(3):147-52
15462415
JAMA. 2010 Mar 17;303(11):1046-53
20233822
J Radiat Res. 2012;53(2):272-80
22129564
Lancet Oncol. 2007 Jun;8(6):475-87
17482880
Int J Radiat Oncol Biol Phys. 2008 Jul 15;71(4):1091-102
18234429
Int J Radiat Oncol Biol Phys. 2004 Jun 1;59(2):348-52
15145147
Int J Radiat Oncol Biol Phys. 2013 Sep 1;87(1):46-52
23778197
Cancer. 2013 May 1;119(9):1729-35
23436283
Int J Radiat Oncol Biol Phys. 2007 Jul 15;68(4):1053-8
17398023
Cancer. 1975 Jun;35(6):1664-77
807318
JAMA. 2012 Apr 18;307(15):1611-20
22511689
Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):e781-6
22331001
Int J Radiat Oncol Biol Phys. 2009 Jun 1;74(2):616-22
19427561
Int J Radiat Oncol Biol Phys. 2011 Oct 1;81(2):390-6
20832180
JAMA. 2005 Sep 14;294(10):1233-9
16160131
Int J Radiat Oncol Biol Phys. 2007 Oct 1;69(2):444-53
17513063
Acta Oncol. 2005;44(8):850-61
16332592
Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):e201-9
21621343
Acta Oncol. 2013 Apr;52(3):492-7
23477360
J Clin Oncol. 2009 Jan 20;27(3):344-51
19064985
Med Phys. 2011 Aug;38(8):4623-33
21928635